NCT06594315View on ClinicalTrials.gov

Assessing Brain Metabolism Using MRS With Deuterated Glucose

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Glioma
Interventions
DRUG

Deuterated Glucose

Given orally

PROCEDURE

Magnetic Resonance Imaging (MRI)

Imaging procedure performed at University of California, San Francisco

PROCEDURE

Blood Sample

Capillary blood from the fingertip

PROCEDURE

MR spectroscopy (MRS)

Imaging procedure performed at University of California, San Francisco

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER